Gene therapy for lysosomal storage diseases.

Area of Science:

• Genetics and Molecular Biology
• Neurology
• Pharmacology

Background:

• Lysosomal storage diseases (LSDs) are a group of inherited genetic disorders.
• LSDs manifest with diverse clinical symptoms affecting both the body and the central nervous system.
• Developing effective treatments for LSDs remains a significant challenge due to their complexity.

Purpose of the Study:

• To review gene replacement strategies for treating lysosomal storage diseases.
• To examine the utility of mouse models in evaluating therapeutic approaches for LSDs.
• To discuss vector systems used in developing long-lasting therapies for fatal LSDs.

Main Methods:

• Review of existing literature on gene replacement strategies for LSDs.
• Analysis of various vector systems employed in therapeutic development.
• Evaluation of mouse models that recapitulate LSD phenotypes for preclinical studies.

Main Results:

• Mouse models are crucial for assessing the efficacy of therapeutic strategies for LSDs.
• Various gene replacement approaches are under investigation for targeting affected organs.
• Different vector systems are being explored to achieve sustained therapeutic effects.

Conclusions:

• Gene replacement therapies hold promise for treating lysosomal storage diseases.
• The selection of appropriate vector systems is critical for achieving long-lasting therapeutic outcomes.
• Continued research using relevant animal models is essential for advancing LSD treatments.